Key Stats
Key stats represent essential financial metrics and indicators used to evaluate a company's performance and potential investment opportunities.
Stock Score/grades
The Stock Score/Grades evaluate bankruptcy risk and assess the financial strength and fundamental health of a company
- Altman Z Score 0.37
- Piotroski Score 5.00
- Grade Buy
- Symbol (MET)
- Company MetLife, Inc.
- Price $82.48
- Changes Percentage (0%)
- Change -$0
- Day Low $81.66
- Day High $82.72
- Year High $82.99
MetLife, Inc., a financial services company, provides insurance, annuities, employee benefits, and asset management services worldwide. It operates through five segments: U.S.; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short-and long-term disability, individual disability, pet insurance, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans; administrative services-only arrangements to employers; and general and separate account, and synthetic guaranteed interest contracts, as well as private floating rate funding agreements. It also provides pension risk transfers, institutional income annuities, structured settlements, and capital markets investment products; and other products and services, such as life insurance products and funding agreements for funding postretirement benefits, as well as company, bank, or trust-owned life insurance used to finance nonqualified benefit programs for executives. In addition, it provides fixed, indexed-linked, and variable annuities; and pension products; regular savings products; whole and term life, endowments, universal and variable life, and group life products; longevity reinsurance solutions; credit insurance products; and protection against long-term health care services. MetLife, Inc. was founded in 1863 and is headquartered in New York, New York.
- Last Earnings 07/09/2024
- Ex-Dividend for 5/16 Dividend 08/06/2024
- Dividend Payable 09/10/2024
- Today N/A
- Next Earnings (Estimated) 10/30/2024
- Fiscal Year End N/A
- Average Stock Price Target $80.00
- High Stock Price Target $145.00
- Low Stock Price Target $74.00
- Potential Upside/Downside N/A
- Consensus Rating Neutral
- Rating Score (0-4) N/A
- Research Coverage N/A
- EPS (Most Recent Fiscal Year) $2.89
- Trailing P/E Ratio 24.24
- Forward P/E Ratio 24.24
- P/E Growth 24.24
- Net Income $1.58 B
Income Statement
Quarterly
Annual
Latest News of MET
The Latest News section aggregates recent news posts from various news outlets, offering a comprehensive overview of the most recent developments related to the topic.
-
Braves vs. Mets live updates: Doubleheader start time, latest news and MLB playoff picture
The Atlanta Braves, New York Mets, and Arizona Diamondbacks are tied for the National League wild-card spots. The Mets and Braves must play a doubleheader to determine the spots, where one win clinche...
By The New York Times | 20 hours ago -
For the Mets, a season's legacy is on the line: How will this team be remembered?
The Mets face a crucial day in Atlanta to determine their season's fate, needing just one win to secure a postseason spot after a roller-coaster ride of a season....
By The New York Times | 21 hours ago -
See The Comet And A 'Ring Of Fire' Eclipse: The Night Sky This Week
Discover the celestial events for the upcoming week, including sightings of the waxing crescent moon with Venus, Comet Tsuchinshan-ATLAS, and a partial solar eclipse. Explore stargazing tips and detai...
By Forbes | 21 hours ago